openPR Logo
Press release

Hyperhidrosis Therapeutics Pipeline Analysis - Dermira, Inc., Allergan, TheraVida, Inc., Brickell Biotech, Inc.

11-20-2018 11:45 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: P&S Intelligence

Hyperhidrosis Therapeutics Pipeline Analysis - Dermira, Inc.,

The study analyzed that the hyperhidrosis therapeutics pipeline comprises approximately 12 drug candidates in different stages of development.

Allergan Plc, TheraVida Inc., and GlaxoSmithKline Plc have one drug candidate each in the Phase II development for the treatment of hyperhidrosis. Glycopyrronium tosylate is the only drug candidate that has the Phase III stage of development for the treatment of hyperhidrosis. Majority of the pipeline drug candidates are being developed using the topical route of administration.

Download report sample at: https://www.psmarketresearch.com/market-analysis/hyperhidrosis-therapeutics-pipeline-analysis/report-sample

Major players in the market are putting more emphasis on targeting cholinergic receptors. The drug candidates used for the treatment of hyperhidrosis, act on cholinergic receptors and block its activity that interfere with sweating. For instance, Glycopyrronium tosylate, a Phase III drug candidate by Dermira, Inc. acts topically and blocks the cholinergic receptor.

Some of the key players developing drugs for the treatment of hyperhidrosis include Dermira, Inc., Allergan plc, TheraVida Inc. and others.

Browse report at: https://www.psmarketresearch.com/market-analysis/hyperhidrosis-therapeutics-pipeline-analysis

Hyperhidrosis Therapeutics Pipeline Analysis
• By Phase
• By Molecule Type
• By Route of Administration
• By Company

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
347 5th Ave. #1402- 210
New York City, NY 10016 United States
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hyperhidrosis Therapeutics Pipeline Analysis - Dermira, Inc., Allergan, TheraVida, Inc., Brickell Biotech, Inc. here

News-ID: 1386845 • Views:

More Releases from P&S Intelligence

Neurology Had the Major Share in the AI-Based Medical imaging Market
Neurology Had the Major Share in the AI-Based Medical imaging Market
The AI-based medical imaging market will generate USD 11,921.4 million 2030, powering at a robust rate of 30.4% by the end of this decade. The key factors powering the industry include the increasing occurrence of chronic ailments, growing requirement for medical services for the elderly populace, and increasing research and development expenditure in the healthcare industry. Furthermore, the incessant progression in imaging tech and the increase in the
Remote Access Provided by Cloud Category Fuels Call Center AI Market
Remote Access Provided by Cloud Category Fuels Call Center AI Market
In 2021, the call center AI market generated sales worth $1,982.9 million, and it is expected to contribute $12,910.6 million in 2030, progressing at a rate of 23.1% from 2021 to 2030, ascribed to the growing up requirements for improved data analytics to manage customer inquiries with the real-time response to improve customer engagement through social media. In order to pace up the 4th industrial revolution, businesses across various industries
Growing Demand for CSM System Will Drive the Customer Engagement Solutions Market
Growing Demand for CSM System Will Drive the Customer Engagement Solutions Marke …
The total value of the customer engagement solutions market was $18,186.8 million in 2021, and it will rise at a growth rate of above 10% in the near future, to reach $43,398.9 million by 2030. The major reasons behind the growth of this industry are growing usage of such solutions in serval industries like healthcare, telecommunications, BFSI and FMCG. North America will grow the fastest with a rate of 10.5% in
Reduced Operational Cost of Energy Efficient Motors Propels Motion Control Market
Reduced Operational Cost of Energy Efficient Motors Propels Motion Control Marke …
The motion control market generated a revenue of $14,887.5 million in 2021, and it is expected to contribute $23,286.4 million in 2030, progressing at a rate of 5.1% from 2021 to 2030, ascribed to the rising demand for industrial robots and integration of components with the motion control systems for convenient use. Moreover, the evolving motion control standards and protocols propel the market, for example, the OPC UA TSN protocol controls

All 5 Releases


More Releases for Dermira

Global Dermatological Therapeutics Market: Technology, Future Trends, Market Opp …
Dermatological Therapeutics Market The global dermatological therapeutics market is valued at USD 34,309 million in 2019 and expected to register a CAGR of 9.6% during the forecast period, 2020–2029. Dermatology is the specialization that deals with the treatment of conditions of the hair, skin, and nails. Dermatological therapeutics involves both clinical and surgical aspects. Generally, dermatologists prefer minimally invasive therapeutic procedures for treating skin disorders. Dermatological medicines can be available over-the-counter as well as on
Palmar Hyperhidrosis Market Comprehensive Analysis on types and application 2020 …
Global Palmar Hyperhidrosis Market Size, Status and Forecast 2020 "Palmar Hyperhidrosis - Pipeline Insight, 2020," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Palmar Hyperhidrosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Our new sample
Topical Use Acne Treatment Market 2020 Dazzling Industry Growth | Dermira, GUTHY …
Global Topical Use Acne Treatment Market is expected to rise from its initial estimated value of USD 5.33 billion in 2018 to an estimated value of USD 7.47 billion by 2026, registering a CAGR of 4.3% in the forecast period of 2019-2026. This rise in market value can be attributed to the rising disposable income. Get Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-topical-use-acne-treatment-market Key Market Competitors: Global Topical Use Acne Treatment Market Few of the major
Axillary Hyperhidrosis Drug Market size, Share, Trends, Business Strategy to 202 …
The market study on the global Axillary Hyperhidrosis Drug Market will include the entire ecosystem of the industry, covering five major regions namely North America, Europe, Asia Pacific, Latin America and Middle East & Africa, and the major countries falling under those regions. The study will feature estimates in terms of sales revenue and consumption from 2019 to 2026, at the global level and across the major regions mentioned above.
Hyperhidrosis Therapeutics - Pipeline Analysis with Key Players Dermira, Inc., A …
The study analyzed that the hyperhidrosis therapeutics pipeline comprises approximately 12 drug candidates in different stages of development. Download report sample at: https://www.psmarketresearch.com/market-analysis/hyperhidrosis-therapeutics-pipeline-analysis/report-sample *Insights on pipeline segments Allergan Plc, TheraVida Inc., and GlaxoSmithKline Plc have one drug candidate each in the Phase II development for the treatment of hyperhidrosis. Glycopyrronium tosylate is the only drug candidate that has the Phase III stage of development for the treatment of hyperhidrosis. Majority of the pipeline
Global Acne Vulgaris Treatment Market 2018-2025 Forecast Analysis: Dermira, Comm …
Acne Vulgaris Treatment Market Research 2018 A market study "Global Acne Vulgaris Treatment Market" examines the performance of the Acne Vulgaris Treatment market 2018. It encloses an in-depth Research of the Acne Vulgaris Treatment market state and the competitive landscape globally. This report analyzes the potential of Acne Vulgaris Treatment market in the present and the future prospects from various angles in detail. Top Manufacturers Analysis and Sellers are Common Pharma Inc,